Manipal Health Enterprises Limited will announce its first quarter FY27 financial results on Thursday, August 20, 2026. Following the announcement, the management team will host an earnings conference call on Friday, August 21, 2026, at 11:00 am IST to discuss the financial performance for the quarter ended June 30, 2026.

The conference call is scheduled under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company notified the Bombay Stock Exchange and the National Stock Exchange of India Limited regarding the event on August 17, 2026.

Conference Call Details

Investors and analysts can participate in the call via the following numbers:

Participants are advised to pre-register using the DiamondPass facility to avoid long queues.

Management Representation

The following executives will lead the discussion:

• Dilip Jose, Managing Director and Chief Executive Officer
• Sameer Agarwal, Chief Financial Officer
• Karthik Rajagopal, Chief Operating Officer

About Manipal Health Enterprises

Manipal Health Enterprises Limited operates a pan-India network of multispecialty hospitals. As of March 31, 2026, the company operated 49 hospitals with 13,037 licensed beds across 14 states and union territories. The network holds the largest pan-India multispecialty hospital bed capacity and is the second-largest hospital chain by number of hospitals in India.

The company leads in bed capacity across three key metro markets: Bengaluru, Kolkata, and Pune. It also maintains leadership positions in Karnataka, Maharashtra, Goa, and select states in eastern India.

Manipal Health Enterprises has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), marking a significant step towards its initial public offering. The company, part of the Manipal Group, operates in the healthcare sector. This filing provides investors with preliminary details regarding the issue size, price band, and key financial metrics.

Company Overview

Manipal Health Enterprises is engaged in the healthcare sector. As part of the broader Manipal Group, the company leverages established brand equity and operational infrastructure. The IPO aims to raise capital for business expansion and strengthening its market position in the healthcare industry.

Offer Details

The company has defined the following parameters for its IPO:

• Price Band: ₹560 to ₹590 per share
• Issue Size: Minimum ₹14,000 crore to Maximum ₹5,00,000 crore
• Minimum Bid Quantity: 25 shares

The objects of the issue and specific timeline for the opening and closing dates will be detailed further as the process advances. Investors are advised to monitor official announcements for updates on the subscription window.

Financial Highlights

Specific financial data such as revenue trends, profit margins, and key ratios were not provided in the current data set. Detailed financial performance metrics will be available in the final prospectus.

Risk Factors

Potential risks associated with the investment include regulatory changes in the healthcare sector, competition from established players, and operational challenges. Specific material risks will be outlined in the final DRHP document.

Valuation & Peer Comparison

Valuation metrics relative to peers are not yet available as the financial data is sparse. A comprehensive peer comparison will be possible once detailed financials and the final issue size are confirmed.

Bottom Line

The filing of the DRHP by Manipal Health Enterprises indicates its readiness to enter the public markets. With a price band of ₹560-₹590 and a substantial issue size range, the IPO attracts attention. Investors should wait for complete financial disclosures before making any decisions.